arGEN-X
Forbes Global 2000 2008 #1176 by revenue Netherlands Healthcare Drugs & Biotechnology
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases.
Forbes Global 2000's description, shown to identify the company. We rate the name, not the business.
- Evocativity EVOC : yellow
- Gen root hints at biotechnology
- Brevity BREV : green
- 6 letters, 2 syllables. Up to seven letters is green, eight at two syllables too; up to ten yellow, eleven or more red.
- Greppability GREP : green
- Found inside 0 other dictionary words.
- Googlability GOOG : green
- Distinctive coined whole
- Pronounceability PRON : yellow
- Argen versus ar-gen-ex is uncertain
- Spellability SPEL : red
- ArGEN-X capitalization and hyphen are inaudible
- Verbability VERB : red
- Technical alphanumeric noun resists verbs
- Nominology
- 59
- All seven dimensions and .com ownership, weighted as set out on Methodology.
- Fluency
- 70
- Brevity and pronounceability only: the subset with published outcome evidence behind it.
- PG grade
- 3 / 4
- Graham's own four-step ladder.
- Exact .com
- Unknown
- Shape
- invented
- Length
- 7 chars, 2 syllables
- Distinctiveness
- suggestive
Watkins SCRATCH flags
- Curse-of-knowledge
- Spelling-challenged
Rubric version 2026.10.20-1, judged by gpt-6.1-sol (agent).
This scores the name only. See Methodology.
These judged dimensions came from an AI agent working through the judging queue in a chat, on the same rubric the scoring pipeline sends. The agent passed the calibration exam before its work was accepted, and each batch it judged hid two names with known answers as a check. The model is named as the agent reported it.